Movatterモバイル変換

Abstract

The CB1 receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB2 receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects. Although many cannabinoid receptor ligands show little, or at best modest, selectivity for either receptor, a number of synthetic compounds are known which have significant selectivity for the CB2 receptor. These include cannabimimetic indoles, such as 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015) and 1-(2,3-dichlorobenzoyl)-2-methyl-3-(2-[1-morpholino] ethyl)-5-methoxyindole (L768242), both of which have good affinity for the CB2 receptor, but weak affinity for the CB1 receptor. Efforts have been made to develop structure-activity relationships (SAR) at CB2 for cannabimimetic indoles, but with limited success. Several derivatives of traditional dibenzopyran based cannabinoids have also been found to have significant selectivity for the CB2 receptor. These include 1- methoxyΔ8-THC derivatives, 1-methoxyΔ8-THC-DMH (L759633), 1-methoxyΔ9(11)-THC-DMH (L759656), and 1-methoxy-3-(1,1-dimethylhexyl)Δ8-THC (JWH-229), plus a number of 1-deoxyΔ8-THC analogues. In particular, 1-deoxy-3-(1,1-dimethylbutyl)Δ8-THC (JWH-133) shows two hundred-fold selectivity for the CB2 receptor. Very recently several compounds belonging to other structural groups have also shown selectivity for the CB2 receptor. This review will describe the current status of the results of these studies and discuss the SAR for these classes of ligands.

Keywords:cannabinoids,deoxy cannabinoids,cb receptor,aminoalkylindoles

« Previous Next »

Rights & Permissions Print Cite

Call for Papers in Thematic Issues

Submission closes on : 09 March, 2026

Biodiversity, Ethnopharmacology, Biotechnology, Bioclimatology and Scientific Education Applied to Toxicology and One Health

Neglected Tropical Diseases (NTDs) are represented by a group of distinct illnesses that affect the most vulnerable segment of the population, negatively impacting the Economy and Public Health. For example, like snakebite, leishmaniasis disproportionately affects vulnerable populations in tropical and subtropical regions. The search for safe drugs against various diseases ...read more

Guest Editor(s):Mr. Andreimar Soares

Submission closes on : 31 December, 2025

Bioprospecting of Natural Products as Sources of New Multitarget Therapies

According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more

Guest Editor(s):Dr. Marcello Iriti

Submission closes on : 09 February, 2026

Chemistry of Materials and Emerging Techniques: Future of Drug Discovery and Medicinal Product Developments

In drug discovery, established knowledge of functional groups, their chemical behaviors, and structure-activity relationships favor chemists to achieve desired efficacy and safety profiles within the novel designed medicinal products. Here, judicious integration of different tools and techniques of chemistry also plays a fundamental role towards the selection of the processes ...read more

Guest Editor(s):Dr. Md Noushad Javed

Submission closes on : 31 December, 2025

Computational Frontiers in Medicinal Chemistry

The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more

Guest Editor(s):Dr. Shaban Ahmad